Is 0383.HK overvalued or undervalued?

0383.HK currently has a P/E ratio of 98.81. Relative to the sector average of 15.80, this suggests the stock may be overvalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Tian An Medicare Limited stock?

Tian An Medicare Limited trades on HKSE. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 0383.HK?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 0383.HK protect my money against local inflation?

Many investors in Latin America buy international stocks like 0383.HK to protect their purchasing power. Because 0383.HK is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 0383.HK shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 0383.HK a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 0383.HK diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks0383.HK

Tian An Medicare Limited

HK$0.83+HK$0.00-15.31%

HKSE / HKD

Market cap

HK$835M

P/E

98.8

EPS (TTM)

HK$0.00

Dividend yield

—

Beta

0.52

1Y return

-12.63%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$188M2021

$184M2022

$201M2023

$209M2024

$210M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.56Low
Current ratio2.03
Cash ratio1.71
Net margin0.5%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

0383.HK98.8
Healthcare sector median15.8
S&P 50022.0

Trades about 525% above its sector, the market expects faster growth.

Ratios

PEG-0.23
Price to book0.50
EPS (TTM)HK$0.00
Payout ratio1,165%
FCF yield-6.20%

Range & risk

HK$0.78HK$1.36

Trading in the lower third of its 52-week band

Beta0.52

Profile

What Tian An Medicare Limited actually does

China Medical & HealthCare Group Limited operates as an investment holding company with its core business centered on managing hospitals across the People's Republic of China, Australia, and the Philippines. The company organizes its diverse activities into six principal segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. Beyond its hospital operations, the group is involved in the development of independent living units and oversees the project management of health campuses dedicated to elderly care and retirement communities. These comprehensive facilities encompass elderly nursing homes, service apartments, independent living units, a shopping mall, various retail shops, and club amenities. Furthermore, the company develops and divests properties and land parcels, leases out residential and commercial office properties, provides money lending services, and delivers additional healthcare provisions. Its scope also extends to the trade of medical apparatus and related supplies, alongside engaging in the buying and selling of securities listed on international exchanges. Established in 1990, the company adopted its current name, China Medical & HealthCare Group Limited, in February 2016, having previously operated as COL Capital Limited. Its corporate headquarters are located in Wanchai, Hong Kong.

CEO

Muk Yin Kong

Employees

2,716

Headquarters

Hong Kong

Founded

1991-08-01

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 0383.HK and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

0383.HK has a beta of 0.52, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Tian An Medicare Limited